NR3C2 and neoplasm: The analysis of silent corticotroph tumors showed a negative correlation between GR immunoreactivity score and tumor size (Spearman R = -0.4518; p = 0.0267) (Figure 2G), however, it was not observed for the relative NR3C1 and NR3C2 expression levels in this patients’ group.